LISA HINEMAN, ANP-C

Lisa Hineman, ANP-C

Senior Director of Clinical Operations

Nurse Practitioner

Lisa Hineman received her BSN from the University of Phoenix, Los Angeles Campus, and her Master’s in Nursing and Nurse Practitioner’s education at California State University, Los Angeles. In addition to patient care as a Nurse Practitioner, she has been involved with the Oncology Nursing Society at local and national levels throughout her career. She has been in Oncology and Hematology for 39 years and has specialization in pain management and has received her certificate in palliative medicine.

 Lisa is a nationally recognized lecturer on cancer therapies, symptom management, health promotion, and improving outcomes. The city of Glendale, California, has recognized her with the “Donald L. Bogdon Cancer Survivor Award” for contributing to the community’s better health and cancer education. She has received various awards, including the “Greater Los Angeles Oncology Nurse of the Year,” the “Advanced Oncology Nurse of the Year” Award, the Astra Zeneca Visions of Hope Award, the Southern California Cancer Pain Initiative Excellence Award, and the Avella CARE Award for Outstanding Nurses.

 She was previously the Chairperson for the women pilot’s organization, “Ninety-Nines Fly for Breast Cancer Awareness,” raising money towards breast cancer research. She was also known as a former Greater Los Angeles Oncology Nursing Society Chapter President, Secretary, Membership, and Government Liaison to Washington. She lobbied on behalf of patients with cancer. She has volunteered for many cancer-related organizations and mentored and taught many nurses and nurse practitioners.

 She is passionate about teaching peers and educating patients. Her goal is to educate people on better care for themselves, attain better health, prevent cancer, or have cancer diagnosed at a curable stage. Her mission is to assist both patients and peers in seeing incurable metastatic cancer moving towards the status of “chronic disease” versus terminal and eventual eradication.